Showing results (221-230 of 250) with videos related to

Sort By:
Pageof 25
Pleura and Peritoneum|March 23, 2026
Multicenter dose de-escalation phase I trial of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) nab-paclitaxel and cisplatin in combination with systemic nab-paclitaxel in recurrent ovarian cancer patients: trial in progressVinita Popat, Paul H Frankel, Nora H Ruel, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 26, 2022
Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney diseaseJanaka Karalliedde, Peter Winocour, Tahseen A Chowdhury, et al.
NPJ Precision Oncology|December 14, 2025
Divergent oncogenic signaling and immune microenvironment changes in low-grade serous ovarian cancer patients undergoing intraperitoneal chemotherapyIsaac Bishara, Patrick A Cosgrove, Sumana Majumdar, et al.
Cancer Immunology, Immunotherapy : CII|June 9, 2023
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancerColt A Egelston, Weihua Guo, Susan E Yost, et al.
Gynecologic Oncology|January 23, 2024
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancerMihaela C Cristea, Daphne Stewart, Timothy Synold, et al.
BMC Nephrology|October 25, 2023
UK Kidney Association Clinical Practice Guideline: Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease 2023 UPDATEAlistair J Roddick, Alexa Wonnacott, David Webb, et al.
Cancer Research Communications|July 25, 2022
Influence of germline BRCA genotype on the survival of patients with triple-negative breast cancerCynthia Villarreal-Garza, Ana S Ferrigno, Alejandro Aranda-Gutierrez, et al.
European Journal of Cancer (Oxford, England : 1990)|July 4, 2021
Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 26, 2022
First-In-Human Pilot PET Immunoimaging Study of 64Cu-Anti-Carcinoembryonic Antigen Monoclonal Antibody (hT84.66-M5A) in Patients with Carcinoembryonic Antigen-Producing CancersJeffrey Y C Wong, David M Yamauchi, Vikram Adhikarla, et al.
Archives of Surgery (Chicago, Ill. : 1960)|November 11, 1999
A multi-institutional study of factors associated with fetal death in injured pregnant patientsF B Rogers, G S Rozycki, T M Osler, et al.
Pageof 25